share_log

ファンペップ---もみ合い、アイ・ブレインサイエンスとアルツハイマー病ワクチンに関する協業契約締結

Fanpep - Consolidation, a cooperative contract concluded with i-Brain Science concerning the Alzheimer's Vaccine.

Fisco Japan ·  Dec 16, 2024 22:00

Consolidation. A partnership contract concerning the Alzheimer's Disease Vaccine has been announced between Ai Brain Science and another entity. Ai Brain Science has already obtained regulatory approval for the neuropsychological testing program "Milevo," which uses a general-purpose tablet as a diagnostic aid for dementia on October 5, 2023. The company has been conducting drug discovery research for an Alzheimer's Disease Vaccine targeting "phosphorylated tau" since November 2023, and both companies aim to develop a simple diagnostic method for Alzheimer's Disease patients, exploring the applicability of eye-tracking diagnostic technology.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment